Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study

Journal:
The Lancet
Published:
Affiliations:
26
Authors:
30
Institutions Authors Share
BMS Switzerland, Switzerland
5.000000
0.17
Bristol-Myers Squibb, United States of America (USA)
4.000000
0.13
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.03
Abramson Cancer Center, Penn, United States of America (USA)
1.000000
0.03
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States of America (USA)
1.000000
0.03
Novant Health, United States of America (USA)
1.000000
0.03
Massachusetts General Hospital (MGH), United States of America (USA)
1.000000
0.03
NIHR University College London Hospitals Biomedical Research Centre, United Kingdom (UK)
1.000000
0.03
University of Cologne (UoC), Germany
1.000000
0.03
Cleveland Clinic, United States of America (USA)
1.000000
0.03
IRCCS Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Italy
1.000000
0.03
Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States of America (USA)
1.000000
0.03
Hôpital Maisonneuve-Rosemont (HMR), Canada
1.000000
0.03
National Cancer Center Hospital, Japan
1.000000
0.03
University of Colorado Cancer Center, United States of America (USA)
1.000000
0.03
Karolinska University Hospital, Sweden
1.000000
0.03
Azienda Ospedaliera Papa Giovanni XXIII, Italy
1.000000
0.03
Institute of Biomedicine of Seville (IBiS), Spain
1.000000
0.03
CommonSpirit Health, United States of America (USA)
1.000000
0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA), France
1.000000
0.03
Institute of Biomedical Research of Salamanca (IBSAL), Spain
0.500000
0.02
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
0.500000
0.02
Montpellier University Hospital, UM, France
0.500000
0.02
French National Centre for Scientific Research (CNRS), France
0.500000
0.02